Sharon Townson - 03 Jun 2024 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GLUE	Stock Option (Right to Buy)	Award	$0	+40,000		$0.000000	40,000	03 Jun 2024	Common Stock	40,000	$3.98	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of this option shall vest and become exercisable on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.